|
CYB5RL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.153810E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.964200E-01 |
| Normal-vs-Stage2 |
8.372800E-01 |
| Normal-vs-Stage3 |
1.112140E-02 |
| Normal-vs-Stage4 |
1.821070E-04 |
| Stage1-vs-Stage2 |
8.389800E-01 |
| Stage1-vs-Stage3 |
4.120000E-03 |
| Stage1-vs-Stage4 |
1.85764999999227E-05 |
| Stage2-vs-Stage3 |
6.213500E-02 |
| Stage2-vs-Stage4 |
2.395100E-03 |
| Stage3-vs-Stage4 |
2.372000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.751580E-01 |
| Normal-vs-AfricanAmerican |
8.000200E-03 |
| Normal-vs-Asian |
9.429000E-01 |
| Caucasian-vs-AfricanAmerican |
8.724300E-02 |
| Caucasian-vs-Asian |
7.752200E-01 |
| AfricanAmerican-vs-Asian |
3.059000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.003040E-01 |
| Normal-vs-Female |
2.645200E-01 |
| Male-vs-Female |
6.089400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.066100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.902400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.234200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.879800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.769200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.508600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.393400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.010000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.661800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.006200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.582990E-01 |
| Normal-vs-Grade 2 |
9.458800E-01 |
| Normal-vs-Grade 3 |
8.068000E-02 |
| Normal-vs-Grade 4 |
8.55359999496486E-08 |
| Grade 1-vs-Grade 2 |
5.769600E-02 |
| Grade 1-vs-Grade 3 |
6.305900E-02 |
| Grade 1-vs-Grade 4 |
5.676900E-03 |
| Grade 2-vs-Grade 3 |
5.520200E-02 |
| Grade 2-vs-Grade 4 |
3.50079998323594E-09 |
| Grade 3-vs-Grade 4 |
1.80240999999581E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.635900E-02 |
| Normal-vs-ccB subtype |
1.577960E-03 |
| ccA subtype-vs-ccB subtype |
7.37280003715313E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.482370E-01 |
| Normal-vs-N1 |
1.952180E-01 |
| N0-vs-N1 |
3.228600E-01 |
|
|
